HealthStream (HSTM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Annual shareholder meeting scheduled for May 28, 2026, at 2:00 p.m. CT, to be held virtually via live webcast.
Proxy materials, including the annual report and proxy statement, are available online, with options for electronic or paper delivery.
Shareholders are encouraged to review all proxy materials before voting and can vote online or by requesting a proxy card.
Voting matters and shareholder proposals
Election of three Class II directors for a three-year term: A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory vote to approve named executive officer compensation as described in the proxy statement.
Proxies may vote on other business that may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and FOR Proposals 2 and 3.
Latest events from HealthStream
- Shareholders will vote virtually on directors, auditor ratification, and executive pay, focusing on governance and ESG.HSTM
Proxy filing10 Apr 2026 - Record 2025 revenue and EBITDA growth, with 2026 guidance projecting further expansion.HSTM
Q4 202513 Mar 2026 - Q2 2024 revenue up 3.4% to $71.6M, guidance reaffirmed, and SaaS platform growth continues.HSTM
Q2 20243 Feb 2026 - Record Q3 revenue, profit growth, and raised guidance highlight strong operational momentum.HSTM
Q3 202419 Jan 2026 - Strong SaaS growth, acquisitions, and platform innovation drive robust 2024 results and 2025 outlook.HSTM
Q4 202423 Dec 2025 - 2025 proxy covers director elections, auditor ratification, executive pay, and ESG priorities.HSTM
Proxy Filing1 Dec 2025 - Annual meeting to address director elections, pay, and auditor ratification.HSTM
Proxy Filing1 Dec 2025 - Record Q2 2025 revenue, profit growth, and a $25M share buyback highlight strong results.HSTM
Q2 202523 Nov 2025 - Revenue up 1%, profit down 17%; guidance trimmed, but cash flow and bookings remain strong.HSTM
Q1 202519 Nov 2025